Combination therapy in hypertension
Otsuka, K.; Tsukiyama, H.; Nozawa, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 2): 198-202
2000
ISSN/ISBN: 0047-1852 PMID: 11028322 Document Number: 512751
Document emailed within 1 workday
Related Documents
Frank, J. 2008: Managing hypertension using combination therapy American Family Physician 77(9): 1279-1286Halawa, B. 1998: Combination therapy in primary hypertension Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 4(19): 35-38
Schrader, J. 1998: Hypertension: pro and contra fixed combination therapy. Pro Fortschritte der Medizin 116(14): 37-38
Huang, M.; Zhu, G.-f.; Cheng, X.-s. 2013: Combination therapy in pulmonary arterial hypertension Zhonghua Xin Xue Guan Bing Za Zhi 41(5): 442-444
Di Veroli, C.; Compagno, S.; Iugoli, A.R. 1982: Spironolactone and propranolol in combination therapy of arterial hypertension La Clinica Terapeutica 103(3): 283-287
Zusman, R.M. 2000: The role of alpha 1-blockers in combination therapy for hypertension International Journal of Clinical Practice 54(1): 36-40
Mikhin, V.P.; Kharchenko, A.V.; Rosliakova, E.A.; Cherniatina, M.A. 2011: Application of coenzyme Q(10) in combination therapy of arterial hypertension Kardiologiia 51(6): 26-31
David, N.A.; Welborn, W.S.; Pierce, H.I. 1975: Comparison of multiple and combination tablet drug therapy in hypertension Current Therapeutic Research 18(6): 741-754
Kato, J.; Eto, T. 2006: Should drug treatment be started with monotherapy or combination therapy for patients with hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 254-257
Rowlands, G.; McConachie, N.A.; Currie, W.J. 1977: Sotalol and bethanidine-an open general practice study in the combination therapy of hypertension British Journal of Clinical Practice 31(5): 57-59
Vaïsse, B.; Silhol, F.; Bouchlagen, K.; Gallois, H.; Poggi, L. 1999: New requirements in the primary treatment of arterial hypertension: why do we need fixed low-dose combination therapy? Presse Medicale 28(9): 500-506
Minami, J.; Ishimitsu, T.; Matsuoka, H. 2005: Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension Nihon Jinzo Gakkai Shi 47(8): 864-869
Salvadeo, A.; Villa, G.; Segagni, S.; Moroni, G.; Poggio, F. 1988: Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension Minerva Cardioangiologica 36(3): 109-113
Jones, D.W.; Sands, C.D. 1991: Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide PharmacoTherapy 11(2): 127-130
Einecke, D. 2012: Compliance promoting hypertension therapy. with early fixed combination more rapid target reading MMW Fortschritte der Medizin 154(7): 29
Hioki, M.; Kagawa, S.; Fujiwara, T.; Sakai, R.; Kojima, T.; Watanabe, Y.; Hashimoto, Y.; Uno, F.; Tanaka, N.; Fujiwara, T. 2008: Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy International Journal of Cancer 122(11): 2628-2633
Teufel, W.; Glocke, M. 1981: Advantages of hypertension therapy with the once daily administration of a combination of beta-blocker and diuretic. Experiences with the self-measurement of blood pressure Therapie der Gegenwart 120(5): 470-485
Akamatsu, H.; Tsukuura, T.; Matsunaga, H.; Suzuki, A. 1993: Study of combination therapy for thymoma: a case of stage IV which presented as total spinal block caused by epidural metastasis and which preoperative combination therapy was effective for minimizing the tumor Kyobu Geka. Japanese Journal of Thoracic Surgery 46(13): 1156-1160
Pan, J.; Lei, L.; Zhao, C. 2018: Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis Clinical and Experimental Rheumatology 36(6): 1095-1102
Lore, W.; Muita, A.K.; Ogola, E.S. 1992: The efficacy and tolerability of enalapril--hydrochlorothiazide combination as a first line therapy in black patients with mild to moderate arterial hypertension: a clinical study in Kenya East African Medical Journal 69(1): 18-21